Annual Retained Earnings
-$919.78 M
-$117.17 M-14.60%
31 December 2023
Summary:
Adverum Biotechnologies annual retained earnings is currently -$919.78 million, with the most recent change of -$117.17 million (-14.60%) on 31 December 2023. During the last 3 years, it has fallen by -$417.24 million (-83.03%). ADVM annual retained earnings is now -25499.14% below its all-time high of -$3.59 million, reached on 31 December 2012.ADVM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$990.17 M
-$27.13 M-2.82%
30 September 2024
Summary:
Adverum Biotechnologies quarterly retained earnings is currently -$990.17 million, with the most recent change of -$27.13 million (-2.82%) on 30 September 2024. Over the past year, it has dropped by -$94.11 million (-10.50%). ADVM quarterly retained earnings is now -11064.44% below its all-time high of -$8.87 million, reached on 31 December 2013.ADVM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.6% | -10.5% |
3 y3 years | -83.0% | -61.4% |
5 y5 years | -186.9% | -170.5% |
ADVM Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -83.0% | at low | -61.4% | at low |
5 y | 5 years | -186.9% | at low | -170.5% | at low |
alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Adverum Biotechnologies Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$990.17 M(+2.8%) |
June 2024 | - | -$963.04 M(+2.0%) |
Mar 2024 | - | -$944.56 M(+2.7%) |
Dec 2023 | -$919.78 M(+14.6%) | -$919.78 M(+2.6%) |
Sept 2023 | - | -$896.06 M(+3.8%) |
June 2023 | - | -$863.18 M(+3.8%) |
Mar 2023 | - | -$831.67 M(+3.6%) |
Dec 2022 | -$802.61 M(+23.8%) | -$802.61 M(+4.3%) |
Sept 2022 | - | -$769.88 M(+5.5%) |
June 2022 | - | -$729.75 M(+6.4%) |
Mar 2022 | - | -$685.98 M(+5.8%) |
Dec 2021 | -$648.08 M(+29.0%) | -$648.08 M(+5.6%) |
Sept 2021 | - | -$613.67 M(+6.7%) |
June 2021 | - | -$575.30 M(+8.3%) |
Mar 2021 | - | -$530.97 M(+5.7%) |
Dec 2020 | -$502.54 M(+30.5%) | -$502.54 M(+8.1%) |
Sept 2020 | - | -$464.90 M(+6.4%) |
June 2020 | - | -$437.13 M(+7.2%) |
Mar 2020 | - | -$407.94 M(+5.9%) |
Dec 2019 | -$385.03 M | -$385.03 M(+5.2%) |
Sept 2019 | - | -$366.10 M(+4.6%) |
June 2019 | - | -$349.99 M(+4.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | -$335.03 M(+4.5%) |
Dec 2018 | -$320.54 M(+26.2%) | -$320.54 M(+5.1%) |
Sept 2018 | - | -$304.88 M(+7.4%) |
June 2018 | - | -$283.93 M(+7.1%) |
Mar 2018 | - | -$265.12 M(+4.4%) |
Dec 2017 | -$254.06 M(+28.4%) | -$254.06 M(+6.2%) |
Sept 2017 | - | -$239.27 M(+6.1%) |
June 2017 | - | -$225.44 M(+5.3%) |
Mar 2017 | - | -$214.01 M(+8.1%) |
Dec 2016 | -$197.91 M(+135.1%) | -$197.91 M(+12.8%) |
Sept 2016 | - | -$175.52 M(+8.9%) |
June 2016 | - | -$161.22 M(+61.9%) |
Mar 2016 | - | -$99.56 M(+18.3%) |
Dec 2015 | -$84.17 M(+129.2%) | -$84.17 M(+20.1%) |
Sept 2015 | - | -$70.07 M(+25.2%) |
June 2015 | - | -$55.99 M(+21.1%) |
Mar 2015 | - | -$46.22 M(+25.9%) |
Dec 2014 | -$36.72 M(+314.0%) | -$36.72 M(+39.5%) |
Sept 2014 | - | -$26.32 M(+45.7%) |
June 2014 | - | -$18.07 M(+36.9%) |
Mar 2014 | - | -$13.20 M(+48.8%) |
Dec 2013 | -$8.87 M(+146.8%) | -$8.87 M |
Dec 2012 | -$3.59 M | - |
FAQ
- What is Adverum Biotechnologies annual retained earnings?
- What is the all time high annual retained earnings for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual retained earnings year-on-year change?
- What is Adverum Biotechnologies quarterly retained earnings?
- What is the all time high quarterly retained earnings for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly retained earnings year-on-year change?
What is Adverum Biotechnologies annual retained earnings?
The current annual retained earnings of ADVM is -$919.78 M
What is the all time high annual retained earnings for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual retained earnings is -$3.59 M
What is Adverum Biotechnologies annual retained earnings year-on-year change?
Over the past year, ADVM annual retained earnings has changed by -$117.17 M (-14.60%)
What is Adverum Biotechnologies quarterly retained earnings?
The current quarterly retained earnings of ADVM is -$990.17 M
What is the all time high quarterly retained earnings for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly retained earnings is -$8.87 M
What is Adverum Biotechnologies quarterly retained earnings year-on-year change?
Over the past year, ADVM quarterly retained earnings has changed by -$94.11 M (-10.50%)